🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12443+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12443 recruiting trials

Phase 3RecruitingNCT06344065

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

👨‍⚕️ Lin Du, Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd📍 1 site📅 Started Dec 2023View details ↗
Phase 4RecruitingNCT05559671

Safety of the Herpes Zoster Subunit Vaccine in Lupus

👨‍⚕️ Amit Saxena, MD, NYU Langone Health📍 2 sites📅 Started Dec 2023View details ↗
NAEnrolling by InvitationNCT06604988

Effectiveness of Video-feedback for Positive Parenting with Children At Risk of ASD

👨‍⚕️ Rosa Vilaseca, Psychology, University of Barcelona📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06528964

Proteinopathies Expression in Skin of Neurodegenerative Disorders

🏥 Universidad Autonoma de San Luis Potosí📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06046222

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

🏥 NS Pharma, Inc.📍 34 sites📅 Started Dec 2023View details ↗
RecruitingNCT06340152

Multi-Omics for Maternal Health After Preeclampsia

👨‍⚕️ Louise Laurent, MD, PhD, UCSD📍 1 site📅 Started Dec 2023View details ↗
Phase 1RecruitingNCT05995782

A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

👨‍⚕️ 1STBIO study manager, 1ST Biotherapeutics, Inc.📍 1 site📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT05912517

A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

👨‍⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 59 sites📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT05948475

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

👨‍⚕️ Milind Javle, MD, M.D. Anderson Cancer Center📍 87 sites📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT05581121

PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

🏥 Institut Claudius Regaud📍 30 sites📅 Started Dec 2023View details ↗
Phase 1RecruitingNCT06150157

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

👨‍⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 31 sites📅 Started Dec 2023View details ↗
RecruitingNCT06214507

Danon Disease Natural History Study

🏥 Rocket Pharmaceuticals Inc.📍 13 sites📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT05931393

Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)

👨‍⚕️ Tian Zhang, MD, University of Texas Southwestern Medical Center📍 1 site📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT06104566

Global Trial in APG2575 for Patients With CLL/SLL

🏥 Ascentage Pharma Group Inc.📍 2 sites📅 Started Dec 2023View details ↗
NARecruitingNCT06190665

DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC

👨‍⚕️ Gao-Jun Teng, Zhongda Hospital📍 2 sites📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06223659

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

👨‍⚕️ Carlo M Contreras, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT05845593

Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)

🏥 Ampel BioSolutions, LLC📍 11 sites📅 Started Dec 2023View details ↗
Phase 1RecruitingNCT06090669

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

👨‍⚕️ Lea C Cunningham, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06252493

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

👨‍⚕️ Onofrio Catalano, MD, Ph.D, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School📍 1 site📅 Started Dec 2023View details ↗
Phase 1, PHASE2RecruitingNCT06016920

Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma

👨‍⚕️ Åse Bratland, MD, PhD, Oslo University Hospital📍 17 sites📅 Started Dec 2023View details ↗
← PreviousPage 349 of 623Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →